Association between mean platelet volume and adiponectin in patients with metabolic syndrome
Metabolic syndrome is a significant pro-inflammatory and pro-coagulant condition. The clinical association of adiponectin, a mainly antidiabetogenic molecule, and its interaction with platelets and platelet indices remains insufficiently investigated. The aim of our study was to investigate the asso...
Uloženo v:
| Vydáno v: | Journal of applied biomedicine Ročník 22; číslo 4; s. 208 - 213 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Poland
01.12.2024
|
| Témata: | |
| ISSN: | 1214-021X, 1214-0287, 1214-0287 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Metabolic syndrome is a significant pro-inflammatory and pro-coagulant condition. The clinical association of adiponectin, a mainly antidiabetogenic molecule, and its interaction with platelets and platelet indices remains insufficiently investigated.
The aim of our study was to investigate the association of adiponectin with platelets and platelet indices in patients with metabolic syndrome.
The investigation was conducted as a cross-sectional study involving 113 subjects: 63 patients with the diagnosis of metabolic syndrome, and 50 healthy controls - with clear inclusion and exclusion criteria. The group of patients with metabolic syndrome was divided into two subgroups according to the platelet/high-density lipoprotein (HDL) ratio.
The subgroup with a higher platelet/HDL ratio was prediabetic. In the same subgroup of patients, a positive correlation between the adiponectin and mean platelet volume (MPV) was seen, while linear regression (95% CI) confirmed the association.
Considering that MPV is the index that indicates average platelet volume and activity, we believe this association with adiponectin can represent a protective compensatory response in patients with metabolic syndrome and prediabetes. Our results provide a basis for a more precise selection of patients in whom the future therapeutic application of recombinant adiponectin would be most effective. |
|---|---|
| AbstractList | Metabolic syndrome is a significant pro-inflammatory and pro-coagulant condition. The clinical association of adiponectin, a mainly antidiabetogenic molecule, and its interaction with platelets and platelet indices remains insufficiently investigated.BACKGROUNDMetabolic syndrome is a significant pro-inflammatory and pro-coagulant condition. The clinical association of adiponectin, a mainly antidiabetogenic molecule, and its interaction with platelets and platelet indices remains insufficiently investigated.The aim of our study was to investigate the association of adiponectin with platelets and platelet indices in patients with metabolic syndrome.OBJECTIVEThe aim of our study was to investigate the association of adiponectin with platelets and platelet indices in patients with metabolic syndrome.The investigation was conducted as a cross-sectional study involving 113 subjects: 63 patients with the diagnosis of metabolic syndrome, and 50 healthy controls - with clear inclusion and exclusion criteria. The group of patients with metabolic syndrome was divided into two subgroups according to the platelet/high-density lipoprotein (HDL) ratio.METHODSThe investigation was conducted as a cross-sectional study involving 113 subjects: 63 patients with the diagnosis of metabolic syndrome, and 50 healthy controls - with clear inclusion and exclusion criteria. The group of patients with metabolic syndrome was divided into two subgroups according to the platelet/high-density lipoprotein (HDL) ratio.The subgroup with a higher platelet/HDL ratio was prediabetic. In the same subgroup of patients, a positive correlation between the adiponectin and mean platelet volume (MPV) was seen, while linear regression (95% CI) confirmed the association.RESULTSThe subgroup with a higher platelet/HDL ratio was prediabetic. In the same subgroup of patients, a positive correlation between the adiponectin and mean platelet volume (MPV) was seen, while linear regression (95% CI) confirmed the association.Considering that MPV is the index that indicates average platelet volume and activity, we believe this association with adiponectin can represent a protective compensatory response in patients with metabolic syndrome and prediabetes. Our results provide a basis for a more precise selection of patients in whom the future therapeutic application of recombinant adiponectin would be most effective.CONCLUSIONConsidering that MPV is the index that indicates average platelet volume and activity, we believe this association with adiponectin can represent a protective compensatory response in patients with metabolic syndrome and prediabetes. Our results provide a basis for a more precise selection of patients in whom the future therapeutic application of recombinant adiponectin would be most effective. Metabolic syndrome is a significant pro-inflammatory and pro-coagulant condition. The clinical association of adiponectin, a mainly antidiabetogenic molecule, and its interaction with platelets and platelet indices remains insufficiently investigated. The aim of our study was to investigate the association of adiponectin with platelets and platelet indices in patients with metabolic syndrome. The investigation was conducted as a cross-sectional study involving 113 subjects: 63 patients with the diagnosis of metabolic syndrome, and 50 healthy controls - with clear inclusion and exclusion criteria. The group of patients with metabolic syndrome was divided into two subgroups according to the platelet/high-density lipoprotein (HDL) ratio. The subgroup with a higher platelet/HDL ratio was prediabetic. In the same subgroup of patients, a positive correlation between the adiponectin and mean platelet volume (MPV) was seen, while linear regression (95% CI) confirmed the association. Considering that MPV is the index that indicates average platelet volume and activity, we believe this association with adiponectin can represent a protective compensatory response in patients with metabolic syndrome and prediabetes. Our results provide a basis for a more precise selection of patients in whom the future therapeutic application of recombinant adiponectin would be most effective. |
| Author | Djukic, Svetlana Djukic, Aleksandar Sekulic, Marija Nesic, Jelena Marinkovic, Milos Petrovic, Ivica Jovanovic, Ivan P |
| Author_xml | – sequence: 1 givenname: Milos surname: Marinkovic fullname: Marinkovic, Milos – sequence: 2 givenname: Jelena surname: Nesic fullname: Nesic, Jelena – sequence: 3 givenname: Ivica surname: Petrovic fullname: Petrovic, Ivica – sequence: 4 givenname: Ivan P surname: Jovanovic fullname: Jovanovic, Ivan P – sequence: 5 givenname: Marija surname: Sekulic fullname: Sekulic, Marija – sequence: 6 givenname: Svetlana surname: Djukic fullname: Djukic, Svetlana – sequence: 7 givenname: Aleksandar surname: Djukic fullname: Djukic, Aleksandar |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40033808$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kEtLAzEURoNU7EOXbiVLN1PzmEeyLMUXFNwouBCGJHMHp8wk4yRj6b832lq48N3F-e6FM0cT6ywgdE3JkrOCZXdbpZeMsHRJGDtDM8pomhAmislpp-9TNPd-S0iWy4JdoGlKCOeCiBn6WHnvTKNC4yzWEHYAFnegLO5bFaCFgL9dO3aAla2wqpo-vjehsThOH2tgg8e7JnzGVlDatY3Bfm-rwXVwic5r1Xq4OuYCvT3cv66fks3L4_N6tUkMEyIkRgupci6lruua5XmuheBZpQVnoKUplKC1oEYIBSITuZKRIEZKniujWEH5At0e7vaD-xrBh7JrvIG2VRbc6EtOC56SImM8ojdHdNQdVGU_NJ0a9uW_kQgkB8AMzvsB6hNCSflnvIzGy1_jZTTOfwC1XnRG |
| Cites_doi | 10.1177/107602960601200203 10.1016/j.biochi.2012.06.008 10.2337/db09-1008 10.1111/j.1538-7836.2008.02982.x 10.3390/jcm12010132 10.1007/s11906-018-0812-z 10.3390/nu13041180 10.1210/er.2008-0024 10.1002/rth2.12266 10.1016/j.metabol.2008.06.008 10.1080/09537104.2016.1224828 10.1536/ihj.48.149 10.1016/j.atherosclerosis.2005.10.034 10.4103/ijpvm.IJPVM_193_20 10.1016/j.heliyon.2023.e21983 10.1007/s00296-019-04349-x 10.1002/dmrr.3403 10.1016/j.atherosclerosis.2020.04.018 10.1038/s41574-019-0230-6 10.1111/j.1464-5491.2006.01858.x 10.1016/j.ecl.2004.03.008 10.1161/01.ATV.0000099786.99623.EF 10.1161/01.ATV.0000194076.84568.81 10.3390/ijms20051190 10.1182/bloodadvances.2021006680 10.2147/VHRM.S48753 10.1016/j.atherosclerosis.2012.12.012 10.1155/2019/9213074 10.1038/s41401-022-00943-1 10.4049/jimmunol.1900899 10.1007/s10557-022-07325-z |
| ContentType | Journal Article |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.32725/jab.2024.022 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1214-0287 |
| EndPage | 213 |
| ExternalDocumentID | 40033808 10_32725_jab_2024_022 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: Faculty of Medical Sciences, the University of Kragujevac grantid: JP 01/23 |
| GroupedDBID | --- --M .~1 0R~ 1~. 29J 2WC 4.4 457 4G. 53G 5GY 7-5 8P~ AAEDT AAIKJ AAOAW AAXLA AAYXX ABDBF ABGSF ABMZM ACGFS ACUHS ADBBV ADEZE AEKER AENEX AGHFR AGUBO AJRQY ALMA_UNASSIGNED_HOLDINGS BAWUL BLXMC CITATION DIK E0C E3Z EBD ECGQY EN8 ESX F5P FDB FIRID FNPLU FRP GBLVA GROUPED_DOAJ ML~ OAUVE OK1 OVT P-8 P-9 P2P P6G PC. SA. TR2 ~8M 9-L AALRI AAXUO ABXDB ACRPL ADNMO ADUQZ AFSHE AGGNV AITUG ANZVX CGR CUY CVF EBS ECM EIF EJD FEDTE HVGLF MET NPM ROL ~Z8 7X8 |
| ID | FETCH-LOGICAL-c288t-cb89a6399bfff2666b8835db832eb9c7a81f81c88ae8586a966b0c9936aca2713 |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001361565700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1214-021X 1214-0287 |
| IngestDate | Sun Sep 28 03:08:00 EDT 2025 Mon May 12 02:38:51 EDT 2025 Sat Nov 29 07:52:00 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Mean platelet volume Metabolic syndrome Platelets Adiponectin |
| Language | English |
| License | https://creativecommons.org/licenses/by-nc-nd/4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c288t-cb89a6399bfff2666b8835db832eb9c7a81f81c88ae8586a966b0c9936aca2713 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://jab.zsf.jcu.cz/doi/10.32725/jab.2024.022.pdf |
| PMID | 40033808 |
| PQID | 3173407523 |
| PQPubID | 23479 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_3173407523 pubmed_primary_40033808 crossref_primary_10_32725_jab_2024_022 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-Dec |
| PublicationDateYYYYMMDD | 2024-12-01 |
| PublicationDate_xml | – month: 12 year: 2024 text: 2024-Dec |
| PublicationDecade | 2020 |
| PublicationPlace | Poland |
| PublicationPlace_xml | – name: Poland |
| PublicationTitle | Journal of applied biomedicine |
| PublicationTitleAlternate | J Appl Biomed |
| PublicationYear | 2024 |
| References | ref13 ref12 ref15 ref14 ref30 ref11 ref10 ref0 ref2 ref1 ref17 ref16 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 |
| References_xml | – ident: ref6 doi: 10.1177/107602960601200203 – ident: ref20 doi: 10.1016/j.biochi.2012.06.008 – ident: ref7 doi: 10.2337/db09-1008 – ident: ref24 doi: 10.1111/j.1538-7836.2008.02982.x – ident: ref17 doi: 10.3390/jcm12010132 – ident: ref25 doi: 10.1007/s11906-018-0812-z – ident: ref12 doi: 10.3390/nu13041180 – ident: ref3 doi: 10.1210/er.2008-0024 – ident: ref23 doi: 10.1002/rth2.12266 – ident: ref14 doi: 10.1016/j.metabol.2008.06.008 – ident: ref19 doi: 10.1080/09537104.2016.1224828 – ident: ref8 doi: 10.1536/ihj.48.149 – ident: ref28 doi: 10.1016/j.atherosclerosis.2005.10.034 – ident: ref18 doi: 10.4103/ijpvm.IJPVM_193_20 – ident: ref2 doi: 10.1016/j.heliyon.2023.e21983 – ident: ref1 doi: 10.1007/s00296-019-04349-x – ident: ref10 doi: 10.1002/dmrr.3403 – ident: ref27 doi: 10.1016/j.atherosclerosis.2020.04.018 – ident: ref26 doi: 10.1038/s41574-019-0230-6 – ident: ref0 doi: 10.1111/j.1464-5491.2006.01858.x – ident: ref4 doi: 10.1016/j.ecl.2004.03.008 – ident: ref16 doi: 10.1161/01.ATV.0000099786.99623.EF – ident: ref11 doi: 10.1161/01.ATV.0000194076.84568.81 – ident: ref29 doi: 10.3390/ijms20051190 – ident: ref9 doi: 10.1182/bloodadvances.2021006680 – ident: ref5 doi: 10.2147/VHRM.S48753 – ident: ref21 doi: 10.1016/j.atherosclerosis.2012.12.012 – ident: ref13 doi: 10.1155/2019/9213074 – ident: ref30 doi: 10.1038/s41401-022-00943-1 – ident: ref15 doi: 10.4049/jimmunol.1900899 – ident: ref22 doi: 10.1007/s10557-022-07325-z |
| SSID | ssj0056972 |
| Score | 2.3230426 |
| Snippet | Metabolic syndrome is a significant pro-inflammatory and pro-coagulant condition. The clinical association of adiponectin, a mainly antidiabetogenic molecule,... |
| SourceID | proquest pubmed crossref |
| SourceType | Aggregation Database Index Database |
| StartPage | 208 |
| SubjectTerms | Adiponectin - blood Adult Blood Platelets - metabolism Blood Platelets - pathology Case-Control Studies Cross-Sectional Studies Female Humans Male Mean Platelet Volume Metabolic Syndrome - blood Middle Aged |
| Title | Association between mean platelet volume and adiponectin in patients with metabolic syndrome |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40033808 https://www.proquest.com/docview/3173407523 |
| Volume | 22 |
| WOSCitedRecordID | wos001361565700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1214-0287 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0056972 issn: 1214-021X databaseCode: DOA dateStart: 20190101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Pb9MwGP3UDTTtMvGbDpiMhLigjMZJY_uIEAgmVnEYqAekyHYSaaNNojarduU_57Mdpx4wCQ5IVVTZjV197-nl2bE_A7yYTFWSJmwS0QLHqinjKhIFKyJdxWqaaVEpO5X99RObzfh8Lj6PRj_8XpjNgtU1v7oS7X-FGssQbLN19h_gHhrFAvyOoOMVYcfrXwEfBHxYhbU08-3tAn0lwvTKKZJL01qct01tRM-ueOyzrPZb3pZlhxQxWbD_lNcgsLLSW1m7l__au_pTHIvX3xvUI7dIf9EMJn5Wrl3piXn0ya1Idyv_-4-bYCnRSYOuf1tj1Ducs6BpsP6jdDpL4zRCa8NCIaY0IFwaqqpN_fCb2ieU2bObLqQ6Nr0cT1wLAcjt0qKcmiPruGvll_TavmoHblE2FcKPyt3DfJoJRl1qVtvb67Cvfdjzd193NTcMVaxlObsDBz1A5I3jyF0YlfU92DvtEboP3wKqkJ4qxFCFeKoQFzOCVCEBVQh-PFWIoQoZqEI8VR7Al_fvzt5-iPrTNiJNOe8irbiQxq-qqqrQtmWKozsvFEp-qYRmkscVjzXnsuRTnkkcJ6uJRnubSS0pi5OHsFvj33gMBF1zlipaJTEKgWJKFQpvEibdnNZxEY_hpY9W3rqkKjkORm2Ec4xwbiKcY4TH8NzHMkfZM--yZF02l-scbW-Sot2lyRgeuSAPTXlQDm-seQL7W1o-hd1udVk-g9t6052vV0eww-b8yPLgJ7_cgYQ |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+mean+platelet+volume+and+adiponectin+in+patients+with+metabolic+syndrome&rft.jtitle=Journal+of+applied+biomedicine&rft.au=Marinkovic%2C+Milos&rft.au=Nesic%2C+Jelena&rft.au=Petrovic%2C+Ivica&rft.au=Jovanovic%2C+Ivan+P&rft.date=2024-12-01&rft.eissn=1214-0287&rft.volume=22&rft.issue=4&rft.spage=208&rft_id=info:doi/10.32725%2Fjab.2024.022&rft_id=info%3Apmid%2F40033808&rft.externalDocID=40033808 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1214-021X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1214-021X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1214-021X&client=summon |